A detailed history of Deutsche Bank Ag\ transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Deutsche Bank Ag\ holds 4,928 shares of CRSP stock, worth $250,539. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,928
Previous 4,814 2.37%
Holding current value
$250,539
Previous $260,000 11.15%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$44.62 - $62.75 $5,086 - $7,153
114 Added 2.37%
4,928 $231,000
Q2 2024

Aug 14, 2024

SELL
$51.17 - $68.18 $19,393 - $25,840
-379 Reduced 7.3%
4,814 $260,000
Q1 2024

May 15, 2024

BUY
$60.67 - $89.12 $8,251 - $12,120
136 Added 2.69%
5,193 $353,000
Q4 2023

Feb 14, 2024

BUY
$38.62 - $72.18 $16,336 - $30,532
423 Added 9.13%
5,057 $316,000
Q3 2023

Nov 09, 2023

BUY
$45.39 - $59.0 $90 - $118
2 Added 0.04%
4,634 $210,000
Q2 2023

Aug 14, 2023

SELL
$43.47 - $67.77 $163,403 - $254,747
-3,759 Reduced 44.8%
4,632 $260,000
Q1 2023

May 15, 2023

BUY
$41.0 - $56.12 $152,684 - $208,990
3,724 Added 79.79%
8,391 $379,000
Q4 2022

Feb 13, 2023

BUY
$39.19 - $65.67 $153,781 - $257,689
3,924 Added 528.13%
4,667 $189,000
Q3 2022

Nov 14, 2022

SELL
$61.1 - $83.78 $7.52 Million - $10.3 Million
-123,149 Reduced 99.4%
743 $49,000
Q2 2022

Aug 11, 2022

SELL
$43.23 - $73.83 $8,559 - $14,618
-198 Reduced 0.16%
123,892 $7.53 Million
Q1 2022

May 13, 2022

BUY
$53.19 - $79.24 $6.46 Million - $9.63 Million
121,485 Added 4663.53%
124,090 $7.79 Million
Q4 2021

Feb 11, 2022

SELL
$70.09 - $111.29 $24,461 - $38,840
-349 Reduced 11.81%
2,605 $197,000
Q3 2021

Nov 04, 2021

SELL
$110.2 - $156.64 $139,182 - $197,836
-1,263 Reduced 29.95%
2,954 $331,000
Q2 2021

Aug 11, 2021

SELL
$100.84 - $161.89 $7.5 Million - $12 Million
-74,365 Reduced 94.63%
4,217 $683,000
Q1 2021

May 13, 2021

SELL
$110.72 - $210.04 $9.15 Million - $17.4 Million
-82,684 Reduced 51.27%
78,582 $9.58 Million
Q4 2020

Feb 16, 2021

BUY
$79.67 - $173.23 $8.58 Million - $18.7 Million
107,681 Added 200.95%
161,266 $24.7 Million
Q3 2020

Nov 12, 2020

SELL
$78.5 - $100.64 $433,163 - $555,331
-5,518 Reduced 9.34%
53,585 $4.48 Million
Q2 2020

Aug 13, 2020

BUY
$38.5 - $76.05 $2.16 Million - $4.26 Million
56,046 Added 1833.37%
59,103 $4.34 Million
Q1 2020

May 14, 2020

SELL
$33.68 - $62.53 $4.41 Million - $8.2 Million
-131,083 Reduced 97.72%
3,057 $130,000
Q4 2019

Feb 14, 2020

BUY
$36.68 - $73.13 $3.57 Million - $7.11 Million
97,244 Added 263.56%
134,140 $8.17 Million
Q3 2019

Nov 14, 2019

BUY
$40.99 - $52.56 $1.49 Million - $1.91 Million
36,420 Added 7651.26%
36,896 $1.51 Million
Q2 2019

Aug 14, 2019

BUY
$35.45 - $48.2 $319 - $433
9 Added 1.93%
476 $21,000
Q1 2019

May 15, 2019

SELL
$28.02 - $40.87 $135,000 - $196,911
-4,818 Reduced 91.16%
467 $16,000
Q4 2018

Feb 14, 2019

SELL
$22.73 - $42.34 $35,163 - $65,499
-1,547 Reduced 22.64%
5,285 $150,000
Q3 2018

Dec 21, 2021

BUY
$44.35 - $65.71 $302,644 - $448,405
6,824 Added 85300.0%
6,832 $303,000
Q3 2018

Nov 14, 2018

SELL
$44.35 - $65.71 $7.2 Million - $10.7 Million
-162,385 Reduced 100.0%
8 $0
Q2 2018

Apr 21, 2020

BUY
$42.62 - $73.59 $296,890 - $512,627
6,966 Added 4.48%
162,393 $9.54 Million
Q2 2018

Aug 14, 2018

BUY
$42.62 - $73.59 $5.58 Million - $9.64 Million
130,992 Added 536.08%
155,427 $9.13 Million
Q1 2018

Oct 18, 2019

BUY
$23.52 - $58.17 $131,265 - $324,646
5,581 Added 29.6%
24,435 $1.12 Million
Q1 2018

May 15, 2018

SELL
$23.52 - $58.17 $926,946 - $2.29 Million
-39,411 Reduced 67.64%
18,854 $860,000
Q4 2017

Feb 14, 2018

BUY
$16.95 - $23.48 $506,482 - $701,605
29,881 Added 105.27%
58,265 $1.37 Million
Q3 2017

Nov 14, 2017

BUY
$16.75 - $20.66 $475,432 - $586,413
28,384
28,384 $506,000

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.97B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.